Published in Gene on December 28, 1989
Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol (1992) 7.23
Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J Virol (1994) 0.88
A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses. Nucleic Acids Res (1993) 0.86
Mutagenesis of diploid mammalian genes by gene entrapment. Nucleic Acids Res (2006) 0.85
Increased susceptibility of transfected prokaryotic and eukaryotic cells to antibiotic selection. Antimicrob Agents Chemother (1992) 0.75
The prognostic value of serum troponin T in unstable angina. N Engl J Med (1992) 5.04
The primary structures of two leghemoglobin genes from soybean. Nucleic Acids Res (1982) 2.64
Codon specific, tRNA dependent in vitro synthesis of ppGpp and pppGpp. Nat New Biol (1973) 2.36
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol (1993) 2.22
Metabolism of guanosine tetraphosphate in Escherichia coli. Eur J Biochem (1972) 2.22
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature (1981) 1.97
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J Virol (1991) 1.92
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA. J Virol (1980) 1.69
Native Escherichia coli HU protein is a heterotypic dimer. FEBS Lett (1979) 1.59
Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus. J Virol (1995) 1.59
The nucleotide sequence of the Akv murine leukemia virus genome. Virology (1984) 1.51
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol (1993) 1.50
Evidence for the non-co-ordinate regulation of ribonucleic acid synthesis in stringent strains of Escherichia coli. J Mol Biol (1968) 1.47
Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J Virol (1988) 1.43
Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci (2000) 1.42
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
Origin of replication, oriC, of the Escherichia coli chromosome: mapping of genes relative to R.EcoRI cleavage sites in the oriC region. Mol Gen Genet (1977) 1.42
Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J Virol (1992) 1.37
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. Proc Natl Acad Sci U S A (1980) 1.36
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl (2002) 1.35
A ribosomal RNA gene, rrnC, of Escherichia coli, mapped by specialized transducing lambdadilv and lambda drbs phages. Mol Gen Genet (1978) 1.31
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Regulation of messenger RNA synthesis in Escherichia coli. J Mol Biol (1968) 1.27
Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J Virol (1989) 1.25
Analysis of the relA gene product of Escherichia coli. Eur J Biochem (1977) 1.22
Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine (1995) 1.19
Chain growth rate of -galactosidase during exponential growth and amino acid starvation. J Mol Biol (1973) 1.17
Anaerobic power and muscle strength characteristics of 11 years old elite and non-elite boys and girls from gymnastics, team handball, tennis and swimming. Scand J Med Sci Sports (2002) 1.17
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus. J Virol (1980) 1.16
Increased cloning efficiency by temperature-cycle ligation. Nucleic Acids Res (1996) 1.14
Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res (2005) 1.14
Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J Virol (1996) 1.12
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Colicin E3 induced cleavage of 16S ribosomal ribonucleic acid; blocking effects of certain antibiotics. Biochemistry (1973) 1.10
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J Virol (1997) 1.07
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo. J Virol (1997) 1.06
Isolation of a lambda transducing bacteriophage carrying the relA gene of Escherichia coli. J Bacteriol (1976) 1.05
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther (1998) 1.04
B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J Virol (1998) 1.04
Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol (1990) 1.04
Protein synthesis and formation of guanosinetetraphosphate. FEBS Lett (1972) 1.04
Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol (2000) 1.03
Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology (2005) 1.03
Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03
Some effects of antibiotics on bacterial polyribosomes as studied by gel electrophoresis. J Mol Biol (1973) 1.01
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci (2000) 1.00
Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol (1991) 0.99
Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer (1992) 0.97
Efficient non-PCR-mediated overlap extension of PCR fragments by exonuclease "end polishing". Biotechniques (1997) 0.97
Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology (1990) 0.97
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol (2000) 0.96
The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med (2008) 0.96
Comparative analysis of RNA tumor virus genomes. Haematol Blood Transfus (1979) 0.96
An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo. J Virol (1997) 0.95
Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers. Virology (2000) 0.95
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants. J Virol (1997) 0.94
Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone (2001) 0.92
Gene structure of the murine 2'-5'-oligoadenylate synthetase family. Cell Mol Life Sci (2002) 0.92
Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4. J Virol (1999) 0.92
E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem (1996) 0.92
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91